Evidence map›Paper›PMID 36864348›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2023

Vitamin D alleviates cognitive dysfunction and brain damage induced by copper sulfate intake in experimental rats: focus on its combination with donepezil.

Mohamed M Elseweidy, Mohamed Mahrous, Sousou I Ali, Mohamed A Shaheen, Nahla N Younis

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Vitamin DNeurochemical research · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohamed M ElseweidyDepartment of Biochemistry, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. mmelseweidy@yahoo.com.ORCID http://orcid.org/0000-0001-8167-7563
Mohamed MahrousDepartment of Biochemistry, Faculty of Pharmacy, Port-Said University, Port-Said, 42526, Egypt.ORCID http://orcid.org/0000-0003-4841-7115
Sousou I AliDepartment of Biochemistry, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Mohamed A ShaheenDepartment of Histology and Cell Biology, Faculty of Human Medicine, Zagazig University, Zagazig, 44519, Egypt.ORCID http://orcid.org/0000-0003-4974-9701
Nahla N YounisDepartment of Biochemistry, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.ORCID http://orcid.org/0000-0003-4747-7095
Zagazig University · EGPort Said University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to demonstrate the potential benefits of donepezil (DPZ) and vitamin D (Vit D) in combination to counteract the neurodegenerative disorders induced by CuSO

Indexed as

Alzheimer DiseaseBrain InjuriesCognitive DysfunctionAcetylcholinesteraseAmyloid Precursor Protein SecretasesAnimalsAntioxidantsAspartic Acid Endopeptidasesbcl-2-Associated X ProteinBrainCopperCopper SulfateDonepezilMaleRatsRats, WistarAcetylcholinesteraseAmyloid Precursor Protein SecretasesAntioxidantsAspartic Acid Endopeptidasesbcl-2-Associated X ProteinCopperCopper SulfateDonepezilSulfatesTumor Necrosis Factor-alphaVitamin DVitaminsAlzheimer’s diseaseCopper sulfateDonepezilNeuroinflammationVitamin D

Identifiers

PMID36864348
PMCPMC10409850
OpenAlexW4322761228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.